Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies and testing methods for identifying mutagenic risks.

J T MacGregor1, D Casciano, L Müller

  • 1FDA Center for Drug Evaluation and Research, 5600 Fishers Lane, Rockville, MD 20857, USA. macgregorj@cder.fda.gov

Mutation Research
|December 13, 2000
PubMed
Summary

This review traces the history of mutagenicity testing, from early concerns to current harmonization efforts. Future directions include quantitative risk assessment and improved predictive models for mutagenic agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.

Frontiers in psychiatry·2026
Same author

Electric-Field-Tunable Spin-Orbit Gap in a Bilayer Graphene/WSe<sub>2</sub> Quantum Dot.

Nano letters·2025
Same author

Opioid prescribing patterns in trauma patients: assessing the impact of injury and treatment factors.

ANZ journal of surgery·2025
Same author

Multiscale Imaging to Monitor Functional SHED-Supported Engineered Vessels.

Journal of dental research·2024
Same author

Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.

ESMO open·2024
Same author

Determinants of beta-lactam PK/PD target attainment in critically ill patients: A single center retrospective study.

Journal of critical care·2024

Area of Science:

  • Toxicology
  • Genetics
  • Risk Assessment

Background:

  • Concerns regarding chemical mutagens' health effects emerged in the 1940s.
  • Regulatory guidelines for mutagenicity testing were established in the 1970s and 1980s.
  • International harmonization of testing guidelines is an ongoing effort.

Purpose of the Study:

  • To discuss the evolution of mutagenicity testing strategies and methods.
  • To summarize efforts toward international harmonization of testing guidelines.
  • To identify current issues and future needs in mutagenicity testing.

Main Methods:

  • Historical review of mutagenicity testing development.
  • Summary of international harmonization initiatives.
  • Discussion of current challenges and future research directions.

Related Experiment Videos

Main Results:

  • The field has progressed from basic identification to complex risk assessment.
  • Key issues include quantitative risk assessment, dose-response, indirect mechanisms, and predictivity for carcinogenicity.
  • Future trends involve updated test batteries and advanced methods like gene expression profiling.

Conclusions:

  • Mutagenicity testing has evolved significantly, driven by health concerns and regulatory needs.
  • Further research is needed for quantitative risk assessment and improved predictive models.
  • The future of testing involves integrating new technologies and species-specific metabolic models.